ID   FNDC5_HUMAN             Reviewed;         212 AA.
AC   Q8NAU1; A6NMC9; D3DPQ6; Q6P6D9; Q7Z676;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2012, sequence version 3.
DT   07-APR-2021, entry version 146.
DE   RecName: Full=Fibronectin type III domain-containing protein 5;
DE   AltName: Full=Fibronectin type III repeat-containing protein 2;
DE   Contains:
DE     RecName: Full=Irisin;
DE   Flags: Precursor;
GN   Name=FNDC5; Synonyms=FRCP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-133 (ISOFORM 1).
RG   The Cancer Genome Anatomy Project (CGAP) at the National Cancer Institute;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 20-212 (ISOFORM 2).
RC   TISSUE=Fetal liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22237023; DOI=10.1038/nature10777;
RA   Bostrom P., Wu J., Jedrychowski M.P., Korde A., Ye L., Lo J.C.,
RA   Rasbach K.A., Bostrom E.A., Choi J.H., Long J.Z., Kajimura S.,
RA   Zingaretti M.C., Vind B.F., Tu H., Cinti S., Hojlund K., Gygi S.P.,
RA   Spiegelman B.M.;
RT   "A PGC1-alpha-dependent myokine that drives brown-fat-like development of
RT   white fat and thermogenesis.";
RL   Nature 481:463-468(2012).
RN   [8]
RP   FUNCTION, INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=24040023; DOI=10.1371/journal.pone.0073680;
RA   Raschke S., Elsen M., Gassenhuber H., Sommerfeld M., Schwahn U.,
RA   Brockmann B., Jung R., Wisloff U., Tjonna A.E., Raastad T., Hallen J.,
RA   Norheim F., Drevon C.A., Romacho T., Eckardt K., Eckel J.;
RT   "Evidence against a Beneficial Effect of Irisin in Humans.";
RL   PLoS ONE 8:E73680-E73680(2013).
CC   -!- FUNCTION: [Irisin]: Contrary to mouse, may not be involved in the
CC       beneficial effects of muscular exercise, nor in the induction of
CC       browning of human white adipose tissue. {ECO:0000269|PubMed:24040023}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22237023};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:22237023}.
CC       Peroxisome membrane {ECO:0000250}; Single-pass type I membrane protein
CC       {ECO:0000250}. Note=Imported in peroxisomes through the PEX5 receptor
CC       pathway. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Irisin]: Secreted. Note=Detected in the blood of
CC       individuals subjected to endurance exercise.
CC       {ECO:0000269|PubMed:22237023}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NAU1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NAU1-2; Sequence=VSP_032861, VSP_032862;
CC       Name=3;
CC         IsoId=Q8NAU1-3; Sequence=VSP_032860, VSP_032863;
CC       Name=4;
CC         IsoId=Q8NAU1-4; Sequence=VSP_032860;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in heart.
CC       Very low expression, if any, in colon, pancreas and spleen.
CC       {ECO:0000269|PubMed:24040023}.
CC   -!- INDUCTION: Has been shown to be up-regulated some twofold by muscular
CC       exercise at the mRNA and protein level; this effect has been suggested
CC       to be mediated by PPARGC1A (PubMed:22237023). However, up-regulation
CC       upon exercise could not be reproduced, at least not at the mRNA level
CC       (PubMed:24040023). {ECO:0000269|PubMed:22237023,
CC       ECO:0000269|PubMed:24040023}.
CC   -!- PTM: The extracellular domain is cleaved and released from the cell
CC       membrane.
CC   -!- PTM: N-Glycosylated. {ECO:0000250}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-76 is the initiator.
CC       Transcript evidence available at present time points at Met-76. In this
CC       short version of the protein, the signal peptide cannot be predicted
CC       and the irisin peptide is severely truncated. The first initiation
CC       codon corresponds to a non-AUG site, an N-terminal ATA codon. This
CC       initiation codon has been annotated as it is in good Kozak context and
CC       it is conserved in other primates, including gibbon, chimpanzee and
CC       gorilla. Although the existence of such a form has not been
CC       demonstrated in human, western blot analysis following endurance
CC       exercise shows the presence of an irisin peptide of similar size in
CC       human and mouse plasma (PubMed:22237023), suggesting the existence of
CC       full-length irisin in human, at least in some tissues. However,
CC       expression from Met-1 may be less efficient than that from Met-76
CC       (PubMed:24040023). {ECO:0000305|PubMed:22237023,
CC       ECO:0000305|PubMed:24040023}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK092102; BAC03806.1; -; mRNA.
DR   EMBL; AC114493; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07499.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07502.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07500.1; -; Genomic_DNA.
DR   EMBL; BC062297; AAH62297.1; -; mRNA.
DR   EMBL; BX537781; CAD97840.1; -; mRNA.
DR   EMBL; BF221649; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS369.2; -. [Q8NAU1-1]
DR   CCDS; CCDS65483.1; -. [Q8NAU1-3]
DR   RefSeq; NP_001165411.2; NM_001171940.1. [Q8NAU1-2]
DR   RefSeq; NP_001165412.1; NM_001171941.2. [Q8NAU1-3]
DR   RefSeq; NP_715637.2; NM_153756.2. [Q8NAU1-1]
DR   PDB; 4LSD; X-ray; 2.28 A; A/B/C/D/E/F/G/H=33-130.
DR   PDBsum; 4LSD; -.
DR   SMR; Q8NAU1; -.
DR   BioGRID; 128948; 13.
DR   IntAct; Q8NAU1; 8.
DR   STRING; 9606.ENSP00000362570; -.
DR   GlyGen; Q8NAU1; 2 sites.
DR   iPTMnet; Q8NAU1; -.
DR   PhosphoSitePlus; Q8NAU1; -.
DR   BioMuta; FNDC5; -.
DR   DMDM; 403314395; -.
DR   jPOST; Q8NAU1; -.
DR   MassIVE; Q8NAU1; -.
DR   PaxDb; Q8NAU1; -.
DR   PeptideAtlas; Q8NAU1; -.
DR   PRIDE; Q8NAU1; -.
DR   ProteomicsDB; 72700; -. [Q8NAU1-1]
DR   ProteomicsDB; 72701; -. [Q8NAU1-2]
DR   ProteomicsDB; 72702; -. [Q8NAU1-3]
DR   ProteomicsDB; 72703; -. [Q8NAU1-4]
DR   Antibodypedia; 54866; 195 antibodies.
DR   DNASU; 252995; -.
DR   Ensembl; ENST00000373471; ENSP00000362570; ENSG00000160097. [Q8NAU1-1]
DR   Ensembl; ENST00000496770; ENSP00000476320; ENSG00000160097. [Q8NAU1-3]
DR   GeneID; 252995; -.
DR   KEGG; hsa:252995; -.
DR   UCSC; uc001bwg.5; human. [Q8NAU1-1]
DR   CTD; 252995; -.
DR   DisGeNET; 252995; -.
DR   GeneCards; FNDC5; -.
DR   HGNC; HGNC:20240; FNDC5.
DR   HPA; ENSG00000160097; Tissue enhanced (skeletal muscle, tongue).
DR   MIM; 611906; gene.
DR   neXtProt; NX_Q8NAU1; -.
DR   OpenTargets; ENSG00000160097; -.
DR   PharmGKB; PA134924607; -.
DR   VEuPathDB; HostDB:ENSG00000160097.15; -.
DR   eggNOG; ENOG502QQCU; Eukaryota.
DR   GeneTree; ENSGT00390000004923; -.
DR   HOGENOM; CLU_089166_2_0_1; -.
DR   InParanoid; Q8NAU1; -.
DR   OrthoDB; 1198350at2759; -.
DR   TreeFam; TF325415; -.
DR   PathwayCommons; Q8NAU1; -.
DR   BioGRID-ORCS; 252995; 3 hits in 861 CRISPR screens.
DR   ChiTaRS; FNDC5; human.
DR   GenomeRNAi; 252995; -.
DR   Pharos; Q8NAU1; Tbio.
DR   PRO; PR:Q8NAU1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q8NAU1; protein.
DR   Bgee; ENSG00000160097; Expressed in quadriceps femoris and 174 other tissues.
DR   ExpressionAtlas; Q8NAU1; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR   GO; GO:0090336; P:positive regulation of brown fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0014850; P:response to muscle activity; ISS:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR032073; FNDC5_C.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF16066; DUF4808; 1.
DR   Pfam; PF00041; fn3; 1.
DR   SMART; SM00060; FN3; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Glycoprotein; Hormone;
KW   Membrane; Peroxisome; Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..212
FT                   /note="Fibronectin type III domain-containing protein 5"
FT                   /id="PRO_0000328971"
FT   CHAIN           32..143
FT                   /note="Irisin"
FT                   /id="PRO_0000415857"
FT   TOPO_DOM        32..152
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        153..173
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        174..212
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          36..127
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOTIF           210..212
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        39
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        84
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..75
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_032860"
FT   VAR_SEQ         180..181
FT                   /note="KD -> EA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_032861"
FT   VAR_SEQ         182..212
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_032862"
FT   VAR_SEQ         212
FT                   /note="I -> VRARPGPGWATLCLMLW (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_032863"
FT   STRAND          38..44
FT                   /evidence="ECO:0007744|PDB:4LSD"
FT   STRAND          50..55
FT                   /evidence="ECO:0007744|PDB:4LSD"
FT   TURN            59..61
FT                   /evidence="ECO:0007744|PDB:4LSD"
FT   STRAND          62..73
FT                   /evidence="ECO:0007744|PDB:4LSD"
FT   STRAND          77..84
FT                   /evidence="ECO:0007744|PDB:4LSD"
FT   STRAND          89..92
FT                   /evidence="ECO:0007744|PDB:4LSD"
FT   STRAND          100..111
FT                   /evidence="ECO:0007744|PDB:4LSD"
FT   STRAND          120..123
FT                   /evidence="ECO:0007744|PDB:4LSD"
SQ   SEQUENCE   212 AA;  23659 MW;  C4A066452A05A134 CRC64;
     MHPGSPSAWP PRARAALRLW LGCVCFALVQ ADSPSAPVNV TVRHLKANSA VVSWDVLEDE
     VVIGFAISQQ KKDVRMLRFI QEVNTTTRSC ALWDLEEDTE YIVHVQAISI QGQSPASEPV
     LFKTPREAEK MASKNKDEVT MKEMGRNQQL RTGEVLIIVV VLFMWAGVIA LFCRQYDIIK
     DNEPNNNKEK TKSASETSTP EHQGGGLLRS KI
//
